554 related articles for article (PubMed ID: 10230646)
1. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
[TBL] [Abstract][Full Text] [Related]
3. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
Yagui K; Kanatsuka A; Makino H
Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
[TBL] [Abstract][Full Text] [Related]
4. Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes.
Kahn SE; Andrikopoulos S; Verchere CB; Wang F; Hull RL; Vidal J
Diabetologia; 2000 Oct; 43(10):1309-12. PubMed ID: 11079750
[TBL] [Abstract][Full Text] [Related]
5. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
Vidal J; Verchere CB; Andrikopoulos S; Wang F; Hull RL; Cnop M; Olin KL; LeBoeuf RC; O'Brien KD; Chait A; Kahn SE
Diabetologia; 2003 Jan; 46(1):71-9. PubMed ID: 12637985
[TBL] [Abstract][Full Text] [Related]
6. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE
Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373
[TBL] [Abstract][Full Text] [Related]
7. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
8. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
10. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.
D'Alessio DA; Verchere CB; Kahn SE; Hoagland V; Baskin DG; Palmiter RD; Ensinck JW
Diabetes; 1994 Dec; 43(12):1457-61. PubMed ID: 7958499
[TBL] [Abstract][Full Text] [Related]
12. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
[TBL] [Abstract][Full Text] [Related]
13. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
[TBL] [Abstract][Full Text] [Related]
14. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice.
Tokuyama Y; Kanatsuka A; Yamaguchi T; Ohsawa H; Makino H; Nishimura M; Yoshida S
Horm Metab Res; 1993 Jun; 25(6):289-91. PubMed ID: 8344641
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
Verchere CB; D'Alessio DA; Palmiter RD; Weir GC; Bonner-Weir S; Baskin DG; Kahn SE
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3492-6. PubMed ID: 8622964
[TBL] [Abstract][Full Text] [Related]
19. Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets.
MacArthur DL; de Koning EJ; Verbeek JS; Morris JF; Clark A
Diabetologia; 1999 Oct; 42(10):1219-27. PubMed ID: 10525663
[TBL] [Abstract][Full Text] [Related]
20. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]